ORAGENICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.01 USD | -1.94% |
|
-4.72% | -82.05% |
| Apr. 12 | North American Morning Briefing : Big Banks Kick -2- | DJ |
| Mar. 29 | Oragenics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 25.28 | 23.07 | 41.2 | 51.91 | 12.36 | 14.46 |
| Enterprise Value (EV) 1 | 5.193 | 5.784 | 24.46 | 25.44 | 1.557 | 11.3 |
| P/E ratio | -0.99 x | -1.42 x | -0.96 x | -3.21 x | -0.89 x | -0.61 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | - | - | - | 596,779,622 x | 93,975,548 x | 383,930,364 x |
| EV / Revenue | - | - | - | 292,498,557 x | 11,842,208 x | 299,979,895 x |
| EV / EBITDA | -0.52 x | -0.37 x | -0.92 x | -1.62 x | -0.11 x | -0.54 x |
| EV / FCF | -0.9 x | -0.75 x | -1.58 x | -3.08 x | -0.15 x | -1.22 x |
| FCF Yield | -111% | -133% | -63.3% | -32.5% | -681% | -81.7% |
| Price to Book | 1.71 x | 2.25 x | 4.26 x | 2.18 x | 1.12 x | 11 x |
| Nbr of stocks (in thousands) | 491 | 735 | 1,529 | 1,940 | 1,960 | 2,569 |
| Reference price 2 | 51.53 | 31.38 | 26.94 | 26.76 | 6.306 | 5.626 |
| Announcement Date | 3/29/19 | 3/4/20 | 3/1/21 | 3/24/22 | 4/17/23 | 3/29/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales | - | - | - | 0.087 | 0.1315 | 0.0377 |
| EBITDA 1 | -9.965 | -15.82 | -26.59 | -15.73 | -14.38 | -20.88 |
| EBIT 1 | -9.995 | -15.88 | -26.64 | -15.77 | -14.42 | -20.9 |
| Operating Margin | - | - | - | -18,131.88% | -10,964.61% | -55,519.89% |
| Earnings before Tax (EBT) 1 | -9.914 | -15.57 | -26.43 | -15.71 | -14.29 | -20.66 |
| Net income 1 | -9.914 | -15.57 | -26.43 | -15.71 | -14.29 | -20.66 |
| Net margin | - | - | - | -18,062.03% | -10,863.96% | -54,858.14% |
| EPS 2 | -52.12 | -22.09 | -28.05 | -8.348 | -7.111 | -9.182 |
| Free Cash Flow 1 | -5.786 | -7.674 | -15.49 | -8.27 | -10.61 | -9.226 |
| FCF margin | - | - | - | -9,507.43% | -8,065.25% | -24,503.94% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/29/19 | 3/4/20 | 3/1/21 | 3/24/22 | 4/17/23 | 3/29/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 0.087 | 0.0151 | 0.0304 | 0.086 | - | 0.017 |
| EBITDA | - | - | - | - | - | - | - |
| EBIT 1 | -4.394 | -2.301 | -6.055 | -4.047 | -3.954 | -0.3604 | -2.905 |
| Operating Margin | - | -2,645.27% | -40,149.4% | -13,317.31% | -4,594.49% | - | -17,067.1% |
| Earnings before Tax (EBT) 1 | -4.384 | -2.293 | -6.035 | -4.033 | -3.918 | -0.3027 | -2.845 |
| Net income 1 | -4.384 | -2.293 | -6.035 | -4.033 | -3.918 | -0.3027 | -2.845 |
| Net margin | - | -2,635.45% | -40,022.48% | -13,269.79% | -4,552.75% | - | -16,714.69% |
| EPS 2 | -2.400 | -1.200 | -3.000 | -1.800 | -1.800 | -0.5400 | -1.410 |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 11/15/21 | 3/24/22 | 5/13/22 | 8/9/22 | 11/14/22 | 4/17/23 | 5/12/23 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 20.1 | 17.3 | 16.7 | 26.5 | 10.8 | 3.16 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -5.79 | -7.67 | -15.5 | -8.27 | -10.6 | -9.23 |
| ROE (net income / shareholders' equity) | -72.9% | -81.7% | -155% | -72.5% | -72.4% | -255% |
| ROA (Net income/ Total Assets) | -42.7% | -47.5% | -86.7% | -42% | -41.9% | -132% |
| Assets 1 | 23.22 | 32.78 | 30.5 | 37.38 | 34.08 | 15.59 |
| Book Value Per Share 2 | 30.10 | 13.90 | 6.320 | 12.30 | 5.640 | 0.5100 |
| Cash Flow per Share 2 | 41.20 | 23.80 | 11.50 | 14.10 | 5.640 | 1.130 |
| Capex 1 | 0.12 | 0.03 | - | 0.04 | 0.13 | - |
| Capex / Sales | - | - | - | 50.44% | 96.96% | - |
| Announcement Date | 3/29/19 | 3/4/20 | 3/1/21 | 3/24/22 | 4/17/23 | 3/29/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -82.05% | 4.62M | |
| -2.63% | 103B | |
| +1.62% | 95.28B | |
| +1.46% | 22.15B | |
| -16.67% | 21.02B | |
| -8.58% | 18.15B | |
| -38.74% | 16.73B | |
| -13.21% | 16.05B | |
| +5.41% | 13.68B | |
| +33.57% | 12.17B |
- Stock Market
- Equities
- OGEN Stock
- Financials Oragenics, Inc.
